LY121a |
Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
LY1001a |
Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LM482a |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed
|
US Biomax |
|
320.00€ |
|
Pub |
NHL802a |
Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
NHL401a |
Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LM801a |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T142a |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
LY121 |
Diffuse large B cell lymphoma tissue array, 12 cases 12 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T385a |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed
|
US Biomax |
|
382.00€ |
|
Pub |
SO751 |
Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FMC405a |
Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T205 |
Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T141a |
Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ME1004a |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
FDA808a-1 |
Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FDA999a |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ME2082a |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed
|
US Biomax |
|
429.00€ |
|
Pub |
LY1001 |
Diffuse large B cell lymphoma tissue array, 100 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
FMC407b |
Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
TH802a |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed
|
US Biomax |
|
320.00€ |
|
Pub |
T175 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FRA901a |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
GL806a |
Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T203a |
Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ST1004 |
Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
T174a |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed
|
US Biomax |
|
81.00€ |
|
Pub |
FMC409a |
Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
CMA241a |
Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
FRA901-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T343 |
Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
SF961 |
Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
ST962 |
Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ST1503 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
CO1502 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed
|
US Biomax |
|
742.00€ |
|
Pub |
T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
ON481 |
Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
811.00€ |
|
Pub |
BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
LC961 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
PRF281 |
Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed
|
US Biomax |
|
742.35€ |
|
Pub |
UT961 |
Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
ES481 |
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed
|
US Biomax |
|
210.00€ |
|
Pub |
FRA901a-2 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c
|
US Biomax |
|
626.00€ |
|
Pub |
FDA902-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
OV961 |
Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
KD1501 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
RE1503 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T214 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
SK961 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T095 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T291a |
Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin
|
US Biomax |
|
114.00€ |
|
Pub |
MO541 |
Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
T176 |
Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
FMC281 |
Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
UT1501 |
Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
CR245 |
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FRA781-2 |
FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
T046 |
Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CR1501 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FRA901a-1 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c
|
US Biomax |
|
626.00€ |
|
Pub |
GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
CO1021 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FRA781-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
CO804a |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
T104 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T014 |
Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
T144 |
Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO488 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
SK245 |
Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
LC817 |
Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
UT243 |
Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme
|
US Biomax |
|
296.00€ |
|
Pub |
TH242 |
Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
T244 |
Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CO962 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T125 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PR484 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
162.00€ |
|
Pub |
T388 |
Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
MBN481 |
Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
FBN401 |
Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
278.00€ |
|
Pub |
VLC12 |
Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
105.00€ |
|
Pub |
FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
FBN407a |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
LV2091 |
Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
429.00€ |
|
Pub |
FRA901-2 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
T024 |
Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
LC488 |
Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
LV1502 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
LC1502 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
PR956 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir
|
US Biomax |
|
487.00€ |
|
Pub |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
114.00€ |
|
Pub |
KD961 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
258.00€ |
|
Pub |
T034 |
Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
90.00€ |
|
Pub |
CyFDA1 |
FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
RE1021 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
296.00€ |
|
Pub |
LC1006 |
Non small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases 100 cores, with stage and grade data, replacing LC1001
|
US Biomax |
|
231.00€ |
|
Pub |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin
|
US Biomax |
|
296.00€ |
|
Pub |
NHL482 |
Lymphoma tissue array, 48 cases 48 cores, replacing NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
NHL803 |
Lymphoma tissue array, 80 cases 80 cores, replacing LM802
|
US Biomax |
|
266.00€ |
|
Pub |
FBN406a |
Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
SK801b |
Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing SK801
|
US Biomax |
|
321.00€ |
|
Pub |
LC808 |
Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases 80 cores, replacing BS04011
|
US Biomax |
|
231.00€ |
|
Pub |
FMO901-2 |
Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed
|
US Biomax |
|
626.00€ |
|
Pub |
ES723 |
Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases 72 cores, replacing BS02031
|
US Biomax |
|
231.00€ |
|
Pub |
LC813 |
Multiple non small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti-
|
US Biomax |
|
296.00€ |
|
Pub |
FFE302a |
Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
394.00€ |
|
Pub |
LC727 |
Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed
|
US Biomax |
|
228.00€ |
|
Pub |
PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed
|
US Biomax |
|
487.00€ |
|
Pub |
LC805 |
Lung large cell carcinoma and bronchioloalveolar carcinoma tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed
|
US Biomax |
|
185.00€ |
|
Pub |
BS04102 |
Large cell carcinoma of lung tissue array, 21 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
NHL803b |
Lymphoma tissue array, 80 cases 80 cores, replacing NHL803
|
US Biomax |
|
321.00€ |
|
Pub |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi
|
US Biomax |
|
429.00€ |
|
Pub |
LC721 |
Non small cell lung carcinoma (NSCLC) tissue array, 24 cases 72 cores, replacing BC04011
|
US Biomax |
|
231.00€ |
|
Pub |
LC10012 |
Lung non small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1006
|
US Biomax |
|
266.00€ |
|
Pub |
KD486 |
Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
MC542 |
Multiple organ diseased tissue array, including TNM and pathology grade, 54 cases 54 cores, replacing MC541
|
US Biomax |
|
160.00€ |
|
Pub |
LC482 |
Non small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases 48 cores, with grade and stage status
|
US Biomax |
|
160.00€ |
|
Pub |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962
|
US Biomax |
|
314.00€ |
|
Pub |
CR803 |
Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases 80 cores, replacing BS10011
|
US Biomax |
|
231.00€ |
|
Pub |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811
|
US Biomax |
|
160.00€ |
|
Pub |
HL481 |
Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LV804 |
Liver cancer tissue array with normal tissue from autopsy, 38 cases 80 cores, replacing BS03011
|
US Biomax |
|
231.00€ |
|
Pub |
LC726 |
Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC04016
|
US Biomax |
|
231.00€ |
|
Pub |
BN243 |
Multiple normal (12 type) tissue array, 12 cases 24 cores, replacing BN241
|
US Biomax |
|
88.00€ |
|
Pub |
ST808 |
Stomach adenocarcinoma and normal tissue array, 80 cases 80 cores, replacing BS01032
|
US Biomax |
|
231.00€ |
|
Pub |
PR809 |
Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases 80 cores, replacing BC19019
|
US Biomax |
|
266.00€ |
|
Pub |
FBN407 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404
|
US Biomax |
|
281.00€ |
|
Pub |
BC04022 |
Non small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LYM1501 |
Lymphoma mid density tissue array, non overlapping with LYM1502, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
MC631 |
Multiple organ, diseased tissue array (63 cases 63 cores, 20 types of cancer and disease), replacing BC00014
|
US Biomax |
|
160.00€ |
|
Pub |
PA802 |
Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases 80 cores, replacing PA801, to be replaced by PA805
|
US Biomax |
|
266.00€ |
|
Pub |
LV809 |
Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases 80 cores, replacing BS03014
|
US Biomax |
|
231.00€ |
|
Pub |
PR8010 |
Prostate cancer tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR802
|
US Biomax |
|
266.00€ |
|
Pub |
T201 |
Lymphoma test tissue array, with normal lymph node control tissues, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
PR955 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR954
|
US Biomax |
|
558.00€ |
|
Pub |
SK483 |
Multiple skin squamous cell carcinoma tissue array with normal tissues control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
T086 |
Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T084
|
US Biomax |
|
88.00€ |
|
Pub |
LC991 |
Lung squamous cell carcinoma (grade I III) tissue array with matched tumor adjacent and normal control, 33 cases 99 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LY2083 |
Lymphoma survey tissue array (3 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR2086 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing BR2001
|
US Biomax |
|
456.00€ |
|
Pub |
CO724 |
Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05031
|
US Biomax |
|
278.00€ |
|
Pub |
SK802 |
Skin squamous cell carcinoma (SCC) tissue array, 80 cases 80 cores, no overlaps with SK801
|
US Biomax |
|
231.00€ |
|
Pub |
CO1002b |
Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases 100 cores, replacing CO1002
|
US Biomax |
|
321.00€ |
|
Pub |
LM803 |
Lymphoma and normal lymph node tissue array, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BN01011b |
Normal stomach tissue array, 24 cases 72 cores, replacing BN01011
|
US Biomax |
|
277.00€ |
|
Pub |
RE722 |
Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases 72 cores, replacing BC06022
|
US Biomax |
|
231.00€ |
|
Pub |
LC641 |
Non small cell lung carcinoma (NSCLC) tissue array, 64 cases 66 cores, with TNM data
|
US Biomax |
|
0.00€ |
|
Pub |
BS02021 |
Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LC10011 |
Non small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
GL811 |
Brain tumor and normal tissue array, with pathology grade, 27 cases 81 cores, replacing BS17011
|
US Biomax |
|
266.00€ |
|
Pub |
LC2081 |
Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information
|
US Biomax |
|
456.00€ |
|
Pub |
FMC409 |
Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401
|
US Biomax |
|
281.00€ |
|
Pub |
BR803 |
Breast carcinoma (multi tissue combined panel) tissue array, 79 cases 80 cores, replacing BC08016
|
US Biomax |
|
189.00€ |
|
Pub |
LY2088 |
Lymphoma tumor tissue array, 208 cases 208 cores
|
US Biomax |
|
558.00€ |
|
Pub |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2
|
US Biomax |
|
336.00€ |
|
Pub |
BR1008 |
Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases 100 cores, replacing BC08212
|
US Biomax |
|
266.00€ |
|
Pub |
ES781 |
Esophagus cancer tissue array, including TNM and pathology grade, 26 cases 78 cores, replacing BC02111
|
US Biomax |
|
266.00€ |
|
Pub |
BN05014 |
Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases 72 cores, replacing BN05011
|
US Biomax |
|
160.00€ |
|
Pub |
BR962 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701
|
US Biomax |
|
231.00€ |
|
Pub |
ST721 |
Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases 72 cores, replacing BC01011
|
US Biomax |
|
231.00€ |
|
Pub |
BC34011 |
Head and neck squamous cell carcinoma tissue array, 24 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
HER2 |
Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases 10 cores; ihc Anti-Actin confirmed
|
US Biomax |
|
114.00€ |
|
Pub |
RAT901 |
Rat multiple organs, normal tissue array, 22 cases 90 cores, replacing BR01013
|
US Biomax |
|
231.00€ |
|
Pub |
LC725 |
Normal lung tissue array, 24 cases 72 cores, replacing BN04011
|
US Biomax |
|
278.00€ |
|
Pub |
ST807 |
Stomach carcinoma (multi tissue combined panel) tissue array (replacing BC01014), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
PR808 |
Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases 80 cores, replacing BC19012
|
US Biomax |
|
266.00€ |
|
Pub |
ME804 |
Malignant melanoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing ME801
|
US Biomax |
|
266.00€ |
|
Pub |
BO601 |
Bone giant cell tumor tissue array, 30 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
TE242 |
Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing TE241
|
US Biomax |
|
88.00€ |
|
Pub |
LM482 |
Myeloma, lymphoma and normal tissue array, 48 cases 48 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BM483 |
Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases 48 cores, replacing BM482
|
US Biomax |
|
266.00€ |
|
Pub |
KD803 |
Normal kidney tissue array, replacing BN07012, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CO806 |
Colon normal adjacent tissue array, replacing BN05012, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ES802 |
Esophageal squamous cell carcinoma tissue array, grade I III, 40 cases 80 cores, no overlaps with ES801
|
US Biomax |
|
231.00€ |
|
Pub |
OS804 |
Osteosarcoma tissue tissue array, with stage and grade, 40 cases 80 cores, replacing BS26011
|
US Biomax |
|
266.00€ |
|
Pub |
LC802 |
Lung small cell carcinoma tissue array (40 cases 80 cores)
|
US Biomax |
|
266.00€ |
|
Pub |
ESC242 |
Esophagus cancer tissue array, 12 cases 24 cores; ihc H&E, IHC anti-Cytokeratin
|
US Biomax |
|
205.00€ |
|
Pub |
BS04071 |
Lung squamous cell carcinoma (grade III) tissue array, 21 cases 63 cores, replaced by LC723
|
US Biomax |
|
160.00€ |
|
Pub |
OV20814 |
Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases 208 cores, replacing OV2084
|
US Biomax |
|
558.00€ |
|
Pub |
MCN602 |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases 60 cores, replacing MCN601
|
US Biomax |
|
231.00€ |
|
Pub |
NHL481 |
Lymphoma tissue array, 48 cases 48 cores, replaced by NHL482
|
US Biomax |
|
189.00€ |
|
Pub |
PA2072 |
Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases 207 cores, replacing PA207
|
US Biomax |
|
456.00€ |
|
Pub |
BR2085c |
Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases 208 cores, replacing BR2085a
|
US Biomax |
|
456.00€ |
|
Pub |
CO723 |
Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05021
|
US Biomax |
|
231.00€ |
|
Pub |
T088 |
Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases 24 cores, replacing T085
|
US Biomax |
|
88.00€ |
|
Pub |
PA241b |
Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases 24 cores, replacing PA241
|
US Biomax |
|
99.00€ |
|
Pub |
BC04118 |
Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LM802 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
MC801 |
Multiple cancer tissue array, replacing BC00012, 80 cases 80 cores, with grade information
|
US Biomax |
|
266.00€ |
|
Pub |
MO1601 |
Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases 160 cores, replacing BM01011
|
US Biomax |
|
278.00€ |
|
Pub |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011
|
US Biomax |
|
231.00€ |
|
Pub |
OV1005 |
Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1001
|
US Biomax |
|
266.00€ |
|
Pub |
SO802 |
Malignant fibrohistiocytoma tissue array, 80 cases 80 cores; ihc CD68 confirmed
|
US Biomax |
|
267.00€ |
|
Pub |
BR8015 |
Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BC08014
|
US Biomax |
|
231.00€ |
|
Pub |
LY2082 |
Lymphoma survey tissue array (2 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
LY2087 |
Lymphoma tumor survey tissue array (2 of 3), 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
OV802 |
Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases 80 cores, replacing BC11011
|
US Biomax |
|
231.00€ |
|
Pub |
BC30013 |
Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995
|
US Biomax |
|
314.00€ |
|
Pub |
BC07013 |
Kidney carcinoma (multi tissue combined panel) tissue array, 23 cases 63 cores, replacing BC07011
|
US Biomax |
|
160.00€ |
|
Pub |
LC724 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04031
|
US Biomax |
|
231.00€ |
|
Pub |
ES961 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores
|
US Biomax |
|
336.00€ |
|
Pub |
BN129 |
Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116
|
US Biomax |
|
160.00€ |
|
Pub |
T392 |
Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T391
|
US Biomax |
|
88.00€ |
|
Pub |
FBN406 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404
|
US Biomax |
|
167.00€ |
|
Pub |
ES1501 |
Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores
|
US Biomax |
|
321.00€ |
|
Pub |
LM481 |
Multiple lymphoma tissue array with normal tissues, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
KD802 |
Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LY802 |
Lymph node metastatic squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC19019 |
Prostate cancer and hyperplasia tissue array, 33 cases 63 cores, replacing BC19011
|
US Biomax |
|
231.00€ |
|
Pub |
BR243a |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243
|
US Biomax |
|
99.00€ |
|
Pub |
LP803 |
Laryngeal squamous cell carcinoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
OS803 |
Chondrosarcoma tissue tissue array, 27 cases 80 cores, replacing BS36011
|
US Biomax |
|
266.00€ |
|
Pub |
BC07115 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases 120 cores
|
US Biomax |
|
321.00€ |
|
Pub |
BS04041 |
Lung squamous cell carcinoma (grade II) tissue array, 21 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BRN801 |
Breast normal adjacent tissue and cancer tissue array, 80 cases 80 cores, replacing BN08013
|
US Biomax |
|
231.00€ |
|
Pub |
LC1009 |
Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T195 |
Prostate adenocarcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, 2 serial sections, replacing T192
|
US Biomax |
|
113.00€ |
|
Pub |
BC110118 |
Ovarian cancer tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC11012
|
US Biomax |
|
231.00€ |
|
Pub |
MC245 |
Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC242
|
US Biomax |
|
88.00€ |
|
Pub |
T084 |
Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases 24 cores, replacing T082
|
US Biomax |
|
88.00€ |
|
Pub |
FCO401a |
Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases 40 cores, replacing FCO401
|
US Biomax |
|
781.00€ |
|
Pub |
BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481
|
US Biomax |
|
189.00€ |
|
Pub |
BN00119 |
Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112
|
US Biomax |
|
266.00€ |
|
Pub |
MO1002 |
Mouse spleen tissue array, 100 cases 100 cores, 50 male and 50 female, replacing MO32011
|
US Biomax |
|
189.00€ |
|
Pub |
PA805 |
Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing PA802
|
US Biomax |
|
266.00€ |
|
Pub |
LC10010 |
Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961
|
US Biomax |
|
266.00€ |
|
Pub |
HN483 |
Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing HN482
|
US Biomax |
|
160.00€ |
|
Pub |
BC08022 |
Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases 63 cores, replacing BN08021
|
US Biomax |
|
160.00€ |
|
Pub |
PR803 |
Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases 80 cores, replacing PR801
|
US Biomax |
|
231.00€ |
|
Pub |
T054 |
Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T052
|
US Biomax |
|
88.00€ |
|
Pub |
LC807 |
Lung cancer and normal tissue array, with TNM and grade info, 77 cases 80 cores, replacing BC04014
|
US Biomax |
|
231.00€ |
|
Pub |
LC1922 |
Middle advanced stage lung non small cell carcinoma tissue array, including TNM and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BL802 |
Bladder cancer tissue array with normal tissue, 80 cases 80 cores, replacing BC12012
|
US Biomax |
|
266.00€ |
|
Pub |
BR8014 |
Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR8012
|
US Biomax |
|
231.00€ |
|
Pub |
T204 |
Lymphoma test tissue array, with normal tissue as control, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
NHL802 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL801, replaced by NHL803
|
US Biomax |
|
266.00€ |
|
Pub |
LY2081 |
Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MC483 |
Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases 48 cores, with stage and grade data
|
US Biomax |
|
160.00€ |
|
Pub |
CO722 |
Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases 72 cores, replacing BC05021
|
US Biomax |
|
231.00€ |
|
Pub |
LY2086 |
Lymphoma tumor tissue array, 208 cases 208 cores
|
US Biomax |
|
633.00€ |
|
Pub |
MC5003 |
High density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases 500 cores, replacing MC5002
|
US Biomax |
|
634.00€ |
|
Pub |
FDA806 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
380.00€ |
|
Pub |
LC242 |
Non small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
ES722 |
Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023
|
US Biomax |
|
231.00€ |
|
Pub |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc
|
US Biomax |
|
429.00€ |
|
Pub |
IC00011b |
Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing IC00011
|
US Biomax |
|
321.00€ |
|
Pub |
LC723 |
Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases 72 cores, replacing BS04071
|
US Biomax |
|
231.00€ |
|
Pub |
ME1004 |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases 100 cores, replacing ME1003
|
US Biomax |
|
314.00€ |
|
Pub |
BN126 |
Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores
|
US Biomax |
|
231.00€ |
|
Pub |
HN811 |
Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases 81 cores, replacing BC34111
|
US Biomax |
|
266.00€ |
|
Pub |
BC081120 |
Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases 110 cores, replacing BC081115
|
US Biomax |
|
266.00€ |
|
Pub |
ES1202 |
Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases 120 cores, replacing ES1201
|
US Biomax |
|
278.00€ |
|
Pub |
TE802 |
Testis seminoma and lymphoma tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LM241 |
Multiple lymphoma tissue array with normal tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
CR244 |
Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases 24 cores, replacing CR241
|
US Biomax |
|
189.00€ |
|
Pub |
LY6161 |
High density lymphoma and normal lymph node tissue array, 322 cases 616 cores
|
US Biomax |
|
753.00€ |
|
Pub |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502
|
US Biomax |
|
278.00€ |
|
Pub |
GL803 |
Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases 80 cores, replacing BS17015
|
US Biomax |
|
266.00€ |
|
Pub |
OS802 |
Osteosarcoma and chondrosarcoma tissue array, with stage, grade and TNM data, 80 cases 80 cores, replacing BC26111
|
US Biomax |
|
266.00€ |
|
Pub |
FDA999 |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998
|
US Biomax |
|
314.00€ |
|
Pub |
BC07114 |
Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases 200 cores
|
US Biomax |
|
558.00€ |
|
Pub |
BC02022 |
Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases 54 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BS04031 |
Lung squamous cell carcinoma tissue array, 63 cases 64 cores, replaced by LC724
|
US Biomax |
|
160.00€ |
|
Pub |
BR728 |
Breast carcinoma tissue array, with stage and grade info, 24 cases 72 cores, replacing BC08015
|
US Biomax |
|
231.00€ |
|
Pub |
NHL401 |
Lymphoma, multiple myeloma and lymph node tissue array, 40 cases 40 cores
|
US Biomax |
|
266.00€ |
|
Pub |
MC244 |
Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
LM801 |
Lymphoma (Hodgkin's and non Hodgkin's disease) tissue array, 80 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
OV602 |
Tissue array of ovarian granulosa theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases 60 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CR484 |
Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases 48 cores
|
US Biomax |
|
225.00€ |
|
Pub |
LYM181 |
Lymphoma tissue array, 18 cases 18 cores
|
US Biomax |
|
166.00€ |
|
Pub |
BC21014 |
Skin malignant tumor tissue array, 78 cases 78 cores, replacing BC21011
|
US Biomax |
|
231.00€ |
|
Pub |
FDA901-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
LV723 |
Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases 72 cores, replacing BC03013
|
US Biomax |
|
231.00€ |
|
Pub |
FFE302 |
Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301
|
US Biomax |
|
199.00€ |
|
Pub |
LC806 |
Multiple types of lung carcinoma tissue array, 80 cases 80 cores, replacing BC04013
|
US Biomax |
|
231.00€ |
|
Pub |
BS04111 |
Lung small cell carcinoma tissue array, 33 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861
|
US Biomax |
|
266.00€ |
|
Pub |
LC1921 |
High density non small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
NHL801 |
Non Hodgkin's lymphoma tissue array, 42 cases 80 cores, no overlaps with NHL802
|
US Biomax |
|
266.00€ |
|
Pub |
LY1501 |
Lymphoma tumor tissue array, 75 cases 150 cores
|
US Biomax |
|
380.00€ |
|
Pub |
GI961 |
GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases 96 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LY2085 |
Lymphoma tumor survey tissue array (5 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
MC5002 |
High density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases 500 cores, replacing MC5001
|
US Biomax |
|
634.00€ |
|
Pub |
CO726 |
Metastatic colon carcinoma tissue array, 24 cases 72 cores, replacing BC050112
|
US Biomax |
|
266.00€ |
|
Pub |
LC241 |
Non small cell lung carcinoma (NSCLC) test tissue array, with self matching normal adjacent tissue, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
LN802 |
Multiple organ lymph tissue array, 80 cases 80 cores, replacing LN801
|
US Biomax |
|
231.00€ |
|
Pub |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952
|
US Biomax |
|
456.00€ |
|
Pub |
RE724 |
Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases 72 cores, replacing BS06041
|
US Biomax |
|
231.00€ |
|
Pub |
BR246a |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing BR246
|
US Biomax |
|
99.00€ |
|
Pub |
BS02041 |
Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LC10013 |
Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, 50 cases 100 cores, replacing LC1002
|
US Biomax |
|
266.00€ |
|
Pub |
ME802 |
Malignant melanoma with normal skin tissue array, 40 cases 80 cores, replacing BS38011
|
US Biomax |
|
266.00€ |
|
Pub |
BO244 |
Human normal bone and osteosarcoma tissue array, 12 cases 24 cores, replacing BO243
|
US Biomax |
|
100.00€ |
|
Pub |
BL806 |
Bladder cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 80 cases 80 cores, replacing BL801
|
US Biomax |
|
266.00€ |
|
Pub |
BR8018 |
Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing BR808, BC08014
|
US Biomax |
|
266.00€ |
|
Pub |
ES2001 |
Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases 200 cores
|
US Biomax |
|
516.00€ |
|
Pub |
BR804 |
Breast tumor tissue array, with matched tumor and adjacent normal tissue, replacing BR801, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CO804 |
Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2
|
US Biomax |
|
277.00€ |
|
Pub |
ES8010 |
Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases 80 cores, replacing ES801
|
US Biomax |
|
231.00€ |
|
Pub |
ST723 |
Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases 72 cores, replacing BS01042
|
US Biomax |
|
231.00€ |
|
Pub |
HL801 |
Hodgkin's lymphoma tissue array, 45 cases 80 cores
|
US Biomax |
|
266.00€ |
|
Pub |
LV805 |
Liver cirrhosis and hepatitis tissue array, 80 cases 80 cores, replacing IC03001
|
US Biomax |
|
231.00€ |
|
Pub |
BC07015 |
Multiple type kidney cancer tissue array with normal tissues, 71 cases 72 cores, replacing BC07012
|
US Biomax |
|
231.00€ |
|
Pub |
T045b |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T045
|
US Biomax |
|
99.00€ |
|
Pub |
BR727 |
Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases 72 cores, replacing BS08011
|
US Biomax |
|
231.00€ |
|
Pub |
LVN801 |
Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BN03011
|
US Biomax |
|
231.00€ |
|
Pub |
SK244 |
Age grouped female skin tissue array, 12 cases 24 cores, replacing SK243
|
US Biomax |
|
99.00€ |
|
Pub |
BC04014 |
Non small cell lung carcinoma (NSCLC) tissue array, 63 cases 63 cores, replaced by LC807
|
US Biomax |
|
160.00€ |
|
Pub |
BR01015 |
Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011
|
US Biomax |
|
278.00€ |
|
Pub |
FDA800 |
Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2
|
US Biomax |
|
266.00€ |
|
Pub |
BR10010 |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases 100 cores, replacing BR1004
|
US Biomax |
|
314.00€ |
|
Pub |
LM721 |
Lymphoma and normal lymph node tissue array, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LYM1502 |
Lymphoma mid density tissue array, non overlapping with LYM1501, 75 cases 150 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BC21011 |
Skin malignant tumor tissue array, 78 cases 78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014
|
US Biomax |
|
231.00€ |
|
Pub |
MC641 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 59 cases 64 cores, replacing BC00115
|
US Biomax |
|
0.00€ |
|
Pub |
FDA901-1 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed
|
US Biomax |
|
858.00€ |
|
Pub |
PR243 |
Prostate cancer and normal tissue array, with stage and grade info, 12 cases 24 cores, replacing PR241
|
US Biomax |
|
88.00€ |
|
Pub |
BN1002 |
Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001
|
US Biomax |
|
266.00€ |
|
Pub |
GL806 |
Brain glioblastoma and normal tissue array, 40 cases 80 cores, replacing GL805
|
US Biomax |
|
266.00€ |
|
Pub |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961
|
US Biomax |
|
266.00€ |
|
Pub |
PR8011 |
Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases 80 cores, replacing PR805
|
US Biomax |
|
314.00€ |
|
Pub |
BN501 |
Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013
|
US Biomax |
|
160.00€ |
|
Pub |
NHL483 |
Non Hodgkin's lymphoma tumor tissue array, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
SK484 |
Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
LY2084 |
Lymphoma tumor survey tissue array (4 of 5), 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
CO725 |
Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases 72 cores, replacing BS05041
|
US Biomax |
|
231.00€ |
|
Pub |
SK803 |
Skin basal cell cancer (BCC) and benign nevus tissue array, 52 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
FDA805 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies
|
US Biomax |
|
314.00€ |
|
Pub |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119
|
US Biomax |
|
336.00€ |
|
Pub |
CR602 |
Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases 60 cores, replacing CR601
|
US Biomax |
|
231.00€ |
|
Pub |
RE723 |
Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases 72 cores, replacing BS06031
|
US Biomax |
|
231.00€ |
|
Pub |
MC802 |
Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases 80 cores, with grade information
|
US Biomax |
|
266.00€ |
|
Pub |
BS02031 |
Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases 63 cores, replaced by ES723
|
US Biomax |
|
160.00€ |
|
Pub |
T386 |
Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases 24 cores, replacing T385
|
US Biomax |
|
88.00€ |
|
Pub |
T174 |
Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases 24 cores, replacing T171
|
US Biomax |
|
88.00€ |
|
Pub |
KD481 |
Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases 48 cores
|
US Biomax |
|
160.00€ |
|
Pub |
OV242 |
Multiple ovarian cancer test tissue array with unmatched normal adjacent tissues, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC000111 |
Multiple organ cancer tissue array, 39 cases 39 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BM01011 |
Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases 160 cores, replaced by MO1601
|
US Biomax |
|
278.00€ |
|
Pub |
CR242 |
Multiple cervix cancer test tissue array with self matching or unmatched normal adjacent tissues, 22 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
RE2081 |
Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ST1921 |
Middle advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T223 |
Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
FMS152 |
Liver of multiple species frozen tissue array, 14 cases 15 cores
|
US Biomax |
|
293.00€ |
|
Pub |
GIST802 |
Multiple organ stromal tumor tissue array (containing stomach, colon, rectum, small intestine, cardia, pancreas, retroperitoneum stroma and pelvic cavity), 80 cases 80 cores, no overlapping with GIST8
|
US Biomax |
|
296.00€ |
|
Pub |
LY241 |
Lymphatic tissue array, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
BC19014 |
Prostate carcinoma tissue array, 31 cases 63 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BR241 |
Breast cancer test tissue array with self matched or unmatched normal adjacent tissues, 6 cases 24 cores.
|
US Biomax |
|
88.00€ |
|
Pub |
CO803 |
Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
T102 |
Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
VLC12 |
Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores
|
US Biomax |
|
88.00€ |
|
Pub |
MNO661 |
Normal organ tissue array of human, 66 cases 66 cores
|
US Biomax |
|
189.00€ |
|
Pub |
LV484 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores
|
US Biomax |
|
231.00€ |
|
Pub |
BC05021 |
Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases 54 cores, no overlapping with BC05022, replaced by CO722
|
US Biomax |
|
231.00€ |
|
Pub |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores
|
US Biomax |
|
266.00€ |
|
Pub |
PR208 |
High density (70 cases 208 cores), multiple prostate cancer (1 4 grade), normal prostate and placenta tissue array
|
US Biomax |
|
456.00€ |
|
Pub |
CO1921 |
High density colon cancer tissue array with normal tissues, 192 cases 192 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T012 |
Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
ES801 |
Esophagus cancer, with matched normal adjacent tissue array, 40 cases 80 cores, replaced by ES8010
|
US Biomax |
|
231.00€ |
|
Pub |
TH805 |
Goiter and thyroiditis tissue array, 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
LP721 |
Laryngeal cancer and normal tissue array, with grade and TNM information, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
BC00115 |
Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802
|
US Biomax |
|
231.00€ |
|
Pub |
BN06011 |
Normal rectum tissue (multi sites) tissue array, 23 cases 63 cores
|
US Biomax |
|
160.00€ |
|
Pub |
RE804 |
Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
ST722 |
Stomach adenocarcinoma with self matched adjacent and normal tissue array, with stage and grade info, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
KIC241 |
Kidney cancer tissue array, 12 cases 24 cores
|
US Biomax |
|
166.00€ |
|
Pub |
T301 |
Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
GL801 |
Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
OS208 |
High density (208 core) tissue microarray of osteosarcoma, chondrosarcoma, giant cell tumor of bone and normal tissue, with TNM data, 69 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
ASM221 |
Cyno monkey normal tissue array, 22 cases 22 cores
|
US Biomax |
|
225.00€ |
|
Pub |
MC806 |
Gangliocytoma and paraganglioma tissue array, 40 cases 80 cores
|
US Biomax |
|
278.00€ |
|
Pub |
COC1501 |
Colon cancer mid density tissue array, non overlapping with either COC1502 or COC1503, 75 cases 150 cores
|
US Biomax |
|
0.00€ |
|
Pub |
SO2084 |
Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
FDA997 |
FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998
|
US Biomax |
|
314.00€ |
|
Pub |
BR20816 |
Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
PR721 |
Prostate cancer normal prostate tissue array with TNM, grade and Gleason scores, 24 cases 72 cores
|
US Biomax |
|
266.00€ |
|
Pub |
CO2089 |
Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T045 |
Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replaced by T045b
|
US Biomax |
|
88.00€ |
|
Pub |
ESC1021 |
Esophagus cancer tissue array, 102 cases 102 cores
|
US Biomax |
|
225.00€ |
|
Pub |
TP242 |
Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
AMS544 |
Mouse normal tissue array, covering 22 organ anatomic sites, 3 cases 54 cores
|
US Biomax |
|
225.00€ |
|
Pub |
ME207b |
High density (69 cases 207 cores), multiple primary melanoma, metastatic and normal skin tissue array block
|
US Biomax |
|
40 981.00€ |
|
Pub |
LUP541 |
Visceral pleura tissue array, 27 cases 54 cores
|
US Biomax |
|
225.00€ |
|
Pub |
BC02013 |
Esophageal carcinoma (multi tissue combined panel) tissue array, 72 cases 72 cores
|
US Biomax |
|
160.00€ |
|
Pub |
BS03014 |
Hepatocellular carcinoma tissue array, 63 cases 63 cores, replaced by LV809
|
US Biomax |
|
160.00€ |
|
Pub |
BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores
|
US Biomax |
|
167.00€ |
|
Pub |
T421 |
Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases 24 cores
|
US Biomax |
|
88.00€ |
|
Pub |
OV20810 |
Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BL2082 |
Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
BR726 |
Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |
CR1001 |
Multiple uterine carcinoma tissue array with normal tissue, 49 cases 100 cores
|
US Biomax |
|
231.00€ |
|
Pub |
SO809 |
Sarcoma tissue array of soft tissue (adipose, fibrous tissue, smooth muscles and striated muscles), 80 cases 80 cores
|
US Biomax |
|
231.00€ |
|
Pub |
KD2083 |
Kidney cancer tissue array with normal tissues, with stage and grade info, 69 cases 208 cores
|
US Biomax |
|
456.00€ |
|
Pub |
T192 |
Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases 24 cores, replaced by T195
|
US Biomax |
|
88.00€ |
|
Pub |
FMC402 |
Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores
|
US Biomax |
|
91.00€ |
|
Pub |
NGL961 |
Nervous system glioma tissue array, 48 cases 96 cores
|
US Biomax |
|
261.00€ |
|
Pub |
LVC962 |
Liver cancer and normal tissue array, non overlapping with LVC961, 48 cases 96 cores
|
US Biomax |
|
189.00€ |
|
Pub |
BC10021 |
Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases 72 cores
|
US Biomax |
|
231.00€ |
|
Pub |